Start the conversation
I made a big call at the very end of 2018.
I did it because the results I was seeing in my proprietary "NICIlytics" cannabis stock analysis were crystal clear: A monster investing trend was beginning to get underway...
So I felt perfectly comfortable predicting "2019 will be the Year of CBD."
In January, CBD was a small niche, a little-known supplement sold only through websites, a handful of health- and wellness-oriented stores, and special pilot programs.
Barely five months into the year, and we're seeing CBD-infused products sold nationwide. Online, of course, but also in shoe stores, malls, and major drug store chains.
Although the CBD boom is still in its very early stages, I still manage to be (pleasantly) surprised by how widely it's spread in such a short time.
In one case, it literally snuck up on me - though I was happy to see it.
Let me show you a quick picture I snapped at the grocery store the other day. In just this one cell phone snap, I captured some potent CBD stocks...
About the Author
Greg Miller started working on Wall Street in September, 1987, just a month before the “Black Monday” stock market crash.
During his career there, he became an expert in just about every kind of publicly traded security - from blue-chip and small-cap stocks to municipals, junk bonds, and derivatives. As a portfolio manager, Greg was responsible for over $500 million of assets in mutual funds and insurance company accounts.
After leaving the Street, he designed a successful options trading strategy and made lucrative tech investments for a financial publication. He has also helped develop new products and worked with other editors to hone their strategies. He’s always been dedicated to deep, fundamental research - and he always will be - because he believes buying the very best companies at the right price is the best way to amass wealth in the stock market.